Publication | Closed Access

Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3

Post-conization High-risk HpvCervical CancerDisease ProgressionNeurovirologyImmunodeficienciesDiagnostic TestCin 2–3PathologyPredicts Residual/recurrent DiseasePublic HealthMedicineEpidemiologyCancer-associated Virus